1. Home
  2. PCRX vs AIOT Comparison

PCRX vs AIOT Comparison

Compare PCRX & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • AIOT
  • Stock Information
  • Founded
  • PCRX 2006
  • AIOT 1993
  • Country
  • PCRX United States
  • AIOT United States
  • Employees
  • PCRX N/A
  • AIOT N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • PCRX Health Care
  • AIOT Telecommunications
  • Exchange
  • PCRX Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • PCRX 1.1B
  • AIOT 785.8M
  • IPO Year
  • PCRX 2011
  • AIOT N/A
  • Fundamental
  • Price
  • PCRX $24.91
  • AIOT $5.59
  • Analyst Decision
  • PCRX Buy
  • AIOT Strong Buy
  • Analyst Count
  • PCRX 9
  • AIOT 3
  • Target Price
  • PCRX $30.67
  • AIOT $12.33
  • AVG Volume (30 Days)
  • PCRX 920.6K
  • AIOT 1.7M
  • Earning Date
  • PCRX 05-06-2025
  • AIOT 04-04-2025
  • Dividend Yield
  • PCRX N/A
  • AIOT N/A
  • EPS Growth
  • PCRX N/A
  • AIOT N/A
  • EPS
  • PCRX N/A
  • AIOT N/A
  • Revenue
  • PCRX $700,966,000.00
  • AIOT $292,953,000.00
  • Revenue This Year
  • PCRX $9.77
  • AIOT $174.10
  • Revenue Next Year
  • PCRX $9.83
  • AIOT $22.01
  • P/E Ratio
  • PCRX N/A
  • AIOT N/A
  • Revenue Growth
  • PCRX 3.85
  • AIOT 119.05
  • 52 Week Low
  • PCRX $11.16
  • AIOT $3.85
  • 52 Week High
  • PCRX $31.67
  • AIOT $8.71
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 55.86
  • AIOT 39.36
  • Support Level
  • PCRX $23.93
  • AIOT $5.67
  • Resistance Level
  • PCRX $25.08
  • AIOT $6.38
  • Average True Range (ATR)
  • PCRX 0.97
  • AIOT 0.33
  • MACD
  • PCRX 0.20
  • AIOT 0.01
  • Stochastic Oscillator
  • PCRX 76.05
  • AIOT 20.20

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: